Veeva Posts A Solid Q2 Report
Aug 29, 2024
Recently re-instated watch list stock Veeva Systems reported its Q2 this week. Sales were up 15%, and profitability rose significantly. This steady and predictable provider of clinical and business software for life sciences firm has a very wide moat and is methodically expanding its product suite into new areas. I love the company but the stock is rarely inexpensive enough to buy. The fair value is $188. After earnings, the stock is trading a good bit above that. We'll leave it on watch.
Follow @GreenDotStocks
Information contained on this website represents only the opinions of the author and should not be used as the sole basis for investing decisions. By using this site, you agree to all statements in the Site Policy.
Watch List
| VEEV | 12.35% |
| SNOW | 52.30% |
| WDAY | -8.24% |
| ENLT | -7.29% |
| WEAV | -20.17% |
| SE | 46.11% |
| SPSC | 15.76% |
| RDDT | 8.84% |
| APPF | 5.96% |
| CMG | 38.44% |
| INTU | 46.55% |
| PSTG | 16.46% |
| CRWD | 118.80% |
| NTNX | 42.70% |
vs. Fair Value Estimates
Buy List
| TBBB | -28.25% |
| SEMR | -34.93% |
| TSM | -30.16% |
| ZETA | -35.35% |
| GOOG | -47.42% |
| HRMY | -51.95% |
| GLBE | -28.44% |
| YOU | -34.88% |
| ABNB | -27.18% |
| ADBE | -37.26% |
vs. Fair Value Estimates
Hold List
| PINS | -19.22% |
| ASML | -14.97% |
| VTEX | 2.56% |
| NYAX | -20.16% |
| MSFT | -16.16% |
| ODD | 15.94% |
| ASR | -21.82% |
| FLYW | -15.37% |
| CELH | 22.90% |
| TOST | 43.30% |
| CPNG | 6.94% |
| HIMS | 43.72% |
| PAYC | -1.32% |
| MNDY | 28.30% |
| ZS | 76.61% |
| V | 0.64% |
| ADSK | 6.98% |
| NOW | 22.24% |
| MELI | -22.42% |
| FTNT | 1.46% |
| TEAM | -11.37% |
vs. Fair Value Estimates